scholarly article | Q13442814 |
P356 | DOI | 10.1002/CNCY.21707 |
P698 | PubMed publication ID | 27412420 |
P50 | author | Mari Mino-Kenudson | Q40930518 |
P2093 | author name string | Eugene J Mark | |
Mai P Hoang | |||
Michiya Nishino | |||
Vicente Morales-Oyarvide | |||
Tiffany G Huynh | |||
Patricia Della Pelle | |||
P2860 | cites work | Aspartic proteinase napsin is a useful marker for diagnosis of primary lung adenocarcinoma | Q24650843 |
Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer | Q27851588 | ||
Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma | Q27860881 | ||
Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer | Q29620301 | ||
p40 (ΔNp63) is superior to p63 for the diagnosis of pulmonary squamous cell carcinoma | Q34067972 | ||
RET, ROS1 and ALK fusions in lung cancer | Q34253845 | ||
The utility of a novel triple marker (combination of TTF1, napsin A, and p40) in the subclassification of non-small cell lung cancer | Q34262527 | ||
Randomized phase II trial comparing bevacizumab plus carboplatin and paclitaxel with carboplatin and paclitaxel alone in previously untreated locally advanced or metastatic non-small-cell lung cancer | Q34323659 | ||
Simultaneous multi-antibody staining in non-small cell lung cancer strengthens diagnostic accuracy especially in small tissue samples | Q34589991 | ||
Diagnosis of lung cancer in small biopsies and cytology: implications of the 2011 International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification | Q35875227 | ||
Suitability of thoracic cytology for new therapeutic paradigms in non-small cell lung carcinoma: high accuracy of tumor subtyping and feasibility of EGFR and KRAS molecular testing | Q37832381 | ||
Dissecting Pulmonary Large-Cell Carcinoma by Targeted Next Generation Sequencing of Several Cancer Genes Pushes Genotypic-Phenotypic Correlations to Emerge | Q41442485 | ||
ΔNp63 (p40) distribution inside lung cancer: a driver biomarker approach to tumor characterization | Q42435605 | ||
Napsin A and thyroid transcription factor-1 expression in carcinomas of the lung, breast, pancreas, colon, kidney, thyroid, and malignant mesothelioma | Q43279006 | ||
Tissue-preserving antibody cocktails to differentiate primary squamous cell carcinoma, adenocarcinoma, and small cell carcinoma of lung. | Q43615551 | ||
Usefulness of TA02 (napsin A) to distinguish primary lung adenocarcinoma from metastatic lung adenocarcinoma | Q44519237 | ||
Napsin A is useful to distinguish primary lung adenocarcinoma from adenocarcinomas of other organs | Q46782763 | ||
Rapid multiplex immunohistochemistry using the 4-antibody cocktail YANA-4 in differentiating primary adenocarcinoma from squamous cell carcinoma of the lung | Q50279861 | ||
Subtyping of undifferentiated non-small cell carcinomas in bronchial biopsy specimens | Q50447151 | ||
TTF-1 and Napsin A double stain: a useful marker for diagnosing lung adenocarcinoma on fine-needle aspiration cell blocks. | Q50546790 | ||
Tissue-sparing application of the newly proposed IASLC/ATS/ERS classification of adenocarcinoma of the lung shows practical diagnostic and prognostic impact. | Q51368447 | ||
Subclassification of non-small cell lung carcinomas lacking morphologic differentiation on biopsy specimens: Utility of an immunohistochemical panel containing TTF-1, napsin A, p63, and CK5/6. | Q51624241 | ||
Utility of 10 immunohistochemical markers including novel markers (desmocollin-3, glypican 3, S100A2, S100A7, and Sox-2) for differential diagnosis of squamous cell carcinoma from adenocarcinoma of the Lung. | Q53244424 | ||
Accuracy of classifying poorly differentiated non-small cell lung carcinoma biopsies with commonly used lung carcinoma markers. | Q53582166 | ||
Human tissue distribution of TA02, which is homologous with a new type of aspartic proteinase, napsin A. | Q54945171 | ||
ΔNp63 (p40) and Thyroid Transcription Factor-1 Immunoreactivity on Small Biopsies or Cellblocks for Typing Non-small Cell Lung Cancer: A Novel Two-Hit, Sparing-Material Approach | Q56779202 | ||
Immunhistochemistry by Means of Widely Agreed-Upon Markers (Cytokeratins 5/6 and 7, p63, Thyroid Transcription Factor-1, and Vimentin) on Small Biopsies of Non-small Cell Lung Cancer Effectively Parallels the Corresponding Profiling and Eventual Diag | Q56779238 | ||
A word of caution regarding napsin A expression in squamous cell carcinomas of the lung | Q83132058 | ||
Value of P63 and CK5/6 in distinguishing squamous cell carcinoma from adenocarcinoma in lung fine-needle aspiration specimens | Q83240488 | ||
Evaluation of napsin A, cytokeratin 5/6, p63, and thyroid transcription factor 1 in adenocarcinoma versus squamous cell carcinoma of the lung | Q83360044 | ||
Combined double CK5/P63 stain: useful adjunct test for diagnosing pulmonary squamous cell carcinoma | Q83802017 | ||
Desmoglein-3 and Napsin A double stain, a useful immunohistochemical marker for differentiation of lung squamous cell carcinoma and adenocarcinoma from other subtypes | Q83864179 | ||
Usefulness of immunohistochemical and histochemical studies in the classification of lung adenocarcinoma and squamous cell carcinoma in cytologic specimens | Q84390051 | ||
Subtyping of non-small cell lung carcinoma: a comparison of small biopsy and cytology specimens | Q84763510 | ||
P433 | issue | 7 | |
P921 | main subject | lung carcinoma | Q18556110 |
P304 | page(s) | 472-484 | |
P577 | publication date | 2016-02-29 | |
P1433 | published in | Cancer Cytopathology | Q13452937 |
P1476 | title | Napsin A/p40 antibody cocktail for subtyping non-small cell lung carcinoma on cytology and small biopsy specimens. | |
P478 | volume | 124 |
Q90354850 | Portrait of Tissue-Specific Coexpression Networks of Noncoding RNAs (miRNA and lncRNA) and mRNAs in Normal Tissues |
Q33648661 | S100A7 promotes lung adenocarcinoma to squamous carcinoma transdifferentiation, and its expression is differentially regulated by the Hippo-YAP pathway in lung cancer cells |
Search more.